Prevalence and determinants of high-risk human papillomavirus infection in women from a sub-Saharan African community

Sexually Transmitted Diseases

Volumn 38, Issue 4, 2011, Pages 308-315

  Sangwa Lugoma, Ghislain ^a,b,c   Ramanakumar, Agnihotram V ^c   Mahmud, Salaheddin ^c   Liaras, Jean ^d   Kayembe, Patrick K ^e   Tozin, Rahma R ^a   Lorincz, Attila ^f   Franco, Eduardo L ^c  

^a UNIVERSITY OF KINSHASA   (Congo)

^b UNIVERSITY OF ALBERTA   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d Groupement de Recherche Cytologique   (France)

^e Ecole de Santé Publique de Kinshasa   (Democratic Republic Congo)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER RISK; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIVORCE; FEMALE; HEALTH BEHAVIOR; HUMAN; IMMUNE FUNCTION TEST; INFECTION RISK; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PROSTITUTION; REPRODUCTIVE EFFORT; SMOKING; UTERINE CERVIX CANCER;

ADULT; CROSS-SECTIONAL STUDIES; DEMOCRATIC REPUBLIC OF THE CONGO; DNA, VIRAL; FEMALE; HUMANS; INTERVIEWS AS TOPIC; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SEXUAL BEHAVIOR; WOMEN'S HEALTH;

EID: 79953166380     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181fc6ec0     Document Type: Article

References (35)

1. Franco EL, Rohan TE, Villa LL. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst 1999; 91:506-511. (Pubitemid 29157058)
2. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55:244-265. (Pubitemid 34293391)
3. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108. (Pubitemid 40372904)
4. de Sanjose S, Diaz M, Castellsague X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. Lancet Infect Dis 2007; 7:453-459. (Pubitemid 46962343)
5. Denny L, Kuhn L, Pollack A, et al. Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer 2000; 89:826-833. (Pubitemid 30658582)
6. Si-Mohamed A, Ndjoyi-Mbiguino A, Cuschieri K, et al. High prevalence of high-risk oncogenic human papillomaviruses harboring atypical distribution in women of childbearing age living in Libreville, Gabon. J Med Virol 2005; 77:430-438. (Pubitemid 41395874)
7. Burchell AN, Winer RL, de Sanjosé S, et al. Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006; 24:S52-S61. (Pubitemid 44293018)
8. Palefsky JM, Holly EA. Molecular virology and epidemiology of human papillomavirus and cervical cancer. Cancer Epidemiol Biomarkers Prev 1995; 4:415-428.
9. Sangwa-Lugoma G, Mahmud S, Nasr SH, et al. Visual inspection as a cervical cancer screening method in a primary health care setting in Africa. Int J Cancer 2006; 119:1389-1395. (Pubitemid 44258816)
10. Xi LF, Touré P, Critchlow CW, et al. Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, west-African women over 35 years of age. Int J Cancer 2003; 103:803-809. (Pubitemid 36110238)
11. Smith JS, Melendy A, Rana RK, et al. Age-specific prevalence of infection with human papillomavirus in females: A global review. J Adolesc Health 2008; 43:S5.e1-S5.e62.
12. Wright TC Jr, Denny L, Kuhn L, et al. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000; 283:81-86. (Pubitemid 30038387)
13. Thomas JO, Herrero R, Omigbodun AA, et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: A population-based study. Br J Cancer 2004; 90:638-645. (Pubitemid 38297204)
14. Wall SR, Scherf CF, Morison L, et al. Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: Viral sequence analysis and epidemiology. Br J Cancer 2005; 93:1068-1076. (Pubitemid 41548404)
15. Castellsagué X, Menéndez C, Loscertales M, et al. Human papillomavirus genotypes in rural Mozambique. Lancet 2001; 358: 1429-1430. (Pubitemid 33055750)
16. De Vuyst H, Steyaert S, Van Renterghem L, et al. Distribution of human papillomavirus in a family planning population in Nairobi, Kenya. Sex Transm Dis 2003; 30:137-142. (Pubitemid 36184362)
17. UNAIDS. AIDS epidemic update: UNAIDS; 2008. Available at: http://data.unaids.org/pub/Report/2008/jc1526-epibriefs-ssafrica-en.pdf. Accessed January 26, 2010.
18. Mayrand MH, Duarte-Franco E, Coutlee F, et al. Randomized controlled trial of human papillomavirus testing versus pap cytology in the primary screening for cervical cancer precursors: Design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST). Int J Cancer 2006; 119:615-623. (Pubitemid 43955716)
19. Serwadda D, Wawer MJ, Shah KV, et al. Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus. J Infect Dis 1999; 180:1316-1319. (Pubitemid 30070219)
20. Franceschi S, Herrero R, Clifford GM, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 2006; 119:2677-2684. (Pubitemid 44691325)
21. Clifford GM. HPV in sub-Saharan Africa [editorial]. Papillomavirus Rep 2005; 16:322-326.
22. Kjaer SK, Svare EI, Worm AM, et al. Human papillomavirus infection in Danish female sex workers: Decreasing prevalence with age despite continuously high sexual activity. Sex Transm Dis 2000; 27:438-445. (Pubitemid 30666945)
23. Jewkes RK, Levin JB, Penn-Kekana LA. Gender inequalities, intimate partner violence and HIV preventive practices: Findings of a South African cross-sectional study. Soc Sci Med 2003; 56:125-134. (Pubitemid 35345164)
24. Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000; 92:464-474. (Pubitemid 30182883)
25. Giuliano AR, Papenfuss MR, Denman CA, et al. Human papillomavirus prevalence at the USA-Mexico border among women 40 years of age and older. Int J STD AIDS 2005; 16:247-251. (Pubitemid 40469863)
26. de Sanjose S, Bosch FX, Munoz N, et al. Socioeconomic differences in cervical cancer: Two case-control studies in Colombia and Spain. Am J Public Health 1996; 86:1532-1538. (Pubitemid 26389209)
27. Castellsague X, Munoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003:20-28.
28. Vaccarella S, Herrero R, Snijders PJ, et al. Smoking and human papillomavirus infection: Pooled analysis of the international agency for research on cancer HPV prevalence surveys. Int J Epidemiol 2008; 37:536-546. (Pubitemid 351804006)
29. Franco EL, Spence AR. Commentary: Smoking and human papillomavirus infection: The pursuit of credibility for an epidemiologic association. Int J Epidemiol 2008; 37:547-548. (Pubitemid 351804007)
30. Bosch FX, de Sanjose S. The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers 2007; 23:213-227. (Pubitemid 47015785)
31. Kjaer SK, van den Brule AJ, Bock JE, et al. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal pap smear: Are there different risk profiles for oncogenic and nononcogenic HPV types? Cancer Epidemiol Biomarkers Prev 1997; 6:799-805. (Pubitemid 27435478)
32. Richardson H, Franco E, Pintos J, et al. Determinants of low-risk and high-risk cervical human papillomavirus infections in Montreal university students. Sex Transm Dis 2000; 27:79-86. (Pubitemid 30082877)
33. Kayembe PK, Fatuma AB, Mapatano MA, et al. Prevalence and determinants of the use of modern contraceptive methods in Kinshasa, Democratic Republic of Congo. Contraception 2006; 74:400-406. (Pubitemid 44527904)
34. Green J, Berrington de Gonzalez A, Smith JS, et al. Human papillomavirus infection and use of oral contraceptives. Br J Cancer 2003; 88:1713-1720. (Pubitemid 36760415)
35. de Villiers EM. Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma. Int J Cancer 2003; 103:705-708.